This episode of PharmTech Explained discusses how China's biotech surge is reshaping US drug licensing, manufacturing control, and FDA data trust, the key shifts pharma professionals must track.
John Stanford
Advertisement
executive director, Incubate Coalition
Articles by John Stanford
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
2
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
5